Sales EmailTemplate

Pharmaceuticals · Marketing Manager · After Invoice

Proposal Follow-Up for Pharmaceuticals Marketing Manager: A…

Use this proposal follow-up template when you're emailing a Marketing Manager in Pharmaceuticals (after an invoice). Money is on the table. The relationship is real. Your job is to make payment simple and keep dignity on both sides. Keep the note aligned with Collaborative and specific. Skip the guru voice.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this proposal follow-up work for a Pharmaceuticals Marketing Manager?

  • Diagnose the stall instead of asking if they 'had a chance to review.'
  • Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
  • Fits how a marketing manager actually reads: A tight 80 to 110 words with one useful observation.
  • Restate number, due date, invoice ID, and pay path in the first screen.
  • Name the decision owner out loud.

When should I send this to a Pharmaceuticals Marketing Manager?

Wait until the review window you agreed on. If none was set, five business days. A polite reminder a few days after due, then a firmer operational note. For this combo, treat "3 days after due date" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a marketing manager, A tight 80 to 110 words with one useful observation. If they named a board week or a freeze, believe it and leave a reopen date.

What this Marketing Manager actually cares about

A marketing manager in Pharmaceuticals is protecting budget, brand risk, and their credibility with sales. They live in campaigns, stakeholders, and a calendar that already overflowed. They reply when you reduce work or show you saw a real gap. The hook that earns a look is a campaign leak, a page that underperforms, or a follow-up sequence that's aging out. The ask should stay at this size: a look at one asset or a 15-minute teardown, not a 'partnership'. Delete trigger: Offering to 'hop on a quick call to explore synergies.'

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Words that work: MLR, label, access, HCP, congress, promotional review. A thread that ignores follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick reads like every other vendor bump.

How should I customize this template before I send it?

  • Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
  • Keep the tone collaborative and specific.
  • Set a decision date in the original proposal so this email has a hook.
  • Time it for 3 days after due date. A polite reminder a few days after due, then a firmer operational note.
  • Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after invoice note?

  • Asking 'any thoughts?' after a 12-page proposal invites silence.
  • Don't threaten, guilt, or bury the amount.
  • Don't use consumer-startup slang. It's a credibility leak.
  • Offering to 'hop on a quick call to explore synergies.'

How does this after invoice scenario compare?

DimensionFor this template
Best send window3 days after due date
Ideal lengthA tight 80 to 110 words with one useful observation.
Primary aska look at one asset or a 15-minute teardown, not a 'partnership'
Industry metric to citetime through MLR, access, and compliant engagement rates
ToneCollaborative and specific. Skip the guru voice.
Unlike proposal follow-upThe commercial terms were already accepted. You're in collections-lite, not sales.
Unlike apologyOnly apologize if you invoiced wrong. Don't apologize for asking to be paid.

What should I copy and send?

Copy-ready template

Subject

Where is the proposal stuck?

Body

Hi [First Name],

Before this sits in a pile, I can cut [option] or split the rollout.

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. Most delays I see are one of four things: scope, price, timing, or who has to sign. Tell me which one and I'll rewrite that section today.

Restate number, due date, invoice ID, and pay path in the first screen.

Which piece is actually blocking a yes or no?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Related templates

Want a custom draft instead? Try the email generator.